Håkan Mellstedt, Professor of Oncologic Biotherapy, M.D., Ph.D., Department of Oncology- Pathology, Karolinska Institute at the Karolinska University Hospital Solna, Stockholm, Sweden.
He is Board Certified in Internal Medicine, Hematology and Oncology. He was president of ESMO 2004 – 2009, chair of the Swedish Medical Society of Oncology 1993-2000 and is member of the Accreditation Council of Oncology in Europe (ACOE) (2009-). He is the co-founder of a biotech company, KANCERA AB, (2011). Professor Mellstedt has published more than 500 manuscripts, and is frequently an invited speaker. He holds several patents.